Omnidermal Overview
- Status
- Private
- Employees
- 6

- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
Omnidermal General Information
Description
Developer of a medical device intended to monitor life cycle of ulcers. The company's Wound Viewer medical device is capable of automatically acquiring and processing ulcer images using an artificial intelligence algorithm,allows to predict the onset of lethal complications and also generates clinical data, enabling physicians and doctors to improve their productivity, reducing the measurement time by more than 10 minutes per visit and to identify immediately the best therapy for the patient, reducing over 30% the risk of clinical complications.
Contact Information
- Via Maria Vittoria 23
- Turin
- Italy
Omnidermal Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Oct-2017 | Completed | Startup |
Omnidermal Executive Team (6)
Omnidermal Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Elia Ricci | Omnidermal | Advisory Board Member | 000 0000 |
Jacopo Secco | Omnidermal | Board Member & Chief Executive Officer | 000 0000 |
Omnidermal Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOmnidermal Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
I3P | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |